Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds

por Radanovic, Igor, Klarenbeek, Naomi, Rissmann, Robert, Groeneveld, Geert Jan, van Brummelen, Emilie M. J., Moerland, Matthijs, Bosch, Jacobus J.
Publicado 2022

A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐Synuclein Peptide Vaccine

por Yu, Hui Jing, Thijssen, Eva, van Brummelen, Emilie, van der Plas, Johan L., Radanovic, Igor, Moerland, Matthijs, Hsieh, Eric, Groeneveld, Geert Jan, Dodart, Jean‐Cosme
Publicado 2022